KLK3 and pure red-cell aplasia: As PSA is an imperfect screening tool and the basis for men of African ancestry being at higher risk of PrCa is fundamentally genetic, combining currently available screening tools such as PSA testing with genetic risk profiling may have the potential to inform screening decisions in men of African ancestry (AFR) [2, 3].